R01 AI036302/AI/NIAID NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1998	1
1999	1
2000	3
2001	2
2002	1
2003	1
2005	3
2006	1
2007	2
2008	2
2009	2
2010	6
2011	3
2012	1
2013	2
2014	2
2015	3
2016	2
2017	4
2018	3
2019	5
2020	3
2021	1
2023	1
2024	0

1

Factors Affecting the Immunity to Respiratory Syncytial Virus: From Epigenetics to Microbiome.

Fonseca W, Lukacs NW, Ptaschinski C. Fonseca W, et al. Front Immunol. 2018 Feb 19;9:226. doi: 10.3389/fimmu.2018.00226. eCollection 2018. Front Immunol. 2018. PMID: 29515570 Free PMC article. Review.

2

TLR Activation and Allergic Disease: Early Life Microbiome and Treatment.

Michels KR, Lukacs NW, Fonseca W. Michels KR, et al. Curr Allergy Asthma Rep. 2018 Sep 26;18(11):61. doi: 10.1007/s11882-018-0815-5. Curr Allergy Asthma Rep. 2018. PMID: 30259206 Review.

3

Early Life Respiratory Syncytial Virus Infection and Asthmatic Responses.

Ptaschinski C, Lukacs NW. Ptaschinski C, et al. Immunol Allergy Clin North Am. 2019 Aug;39(3):309-319. doi: 10.1016/j.iac.2019.03.002. Epub 2019 Apr 30. Immunol Allergy Clin North Am. 2019. PMID: 31284922 Review.

4

Recent Advances in Understanding the Human Fungal Pathogen Hypoxia Response in Disease Progression.

Puerner C, Vellanki S, Strauch JL, Cramer RA. Puerner C, et al. Annu Rev Microbiol. 2023 Sep 15;77:403-425. doi: 10.1146/annurev-micro-032521-021745. Annu Rev Microbiol. 2023. PMID: 37713457 Free PMC article. Review.

5

The Histone Methyltransferase Setdb2 Modulates Macrophage Phenotype and Uric Acid Production in Diabetic Wound Repair.

Kimball AS, Davis FM, denDekker A, Joshi AD, Schaller MA, Bermick J, Xing X, Burant CF, Obi AT, Nysz D, Robinson S, Allen R, Lukacs NW, Henke PK, Gudjonsson JE, Moore BB, Kunkel SL, Gallagher KA. Kimball AS, et al. Immunity. 2019 Aug 20;51(2):258-271.e5. doi: 10.1016/j.immuni.2019.06.015. Epub 2019 Jul 23. Immunity. 2019. PMID: 31350176 Free PMC article.

6

The respiratory tract microbiome and lung inflammation: a two-way street.

Huffnagle GB, Dickson RP, Lukacs NW. Huffnagle GB, et al. Mucosal Immunol. 2017 Mar;10(2):299-306. doi: 10.1038/mi.2016.108. Epub 2016 Dec 14. Mucosal Immunol. 2017. PMID: 27966551 Free PMC article. Review.

7

Association of IL-13 in respiratory syncytial virus-induced pulmonary disease: still a promising target.

Mukherjee S, Lukacs NW. Mukherjee S, et al. Expert Rev Anti Infect Ther. 2010 Jun;8(6):617-21. doi: 10.1586/eri.10.39. Expert Rev Anti Infect Ther. 2010. PMID: 20521887 Free PMC article. No abstract available.

8

IL-17E (IL-25) and IL-17RB promote respiratory syncytial virus-induced pulmonary disease.

Petersen BC, Dolgachev V, Rasky A, Lukacs NW. Petersen BC, et al. J Leukoc Biol. 2014 May;95(5):809-815. doi: 10.1189/jlb.0913482. Epub 2014 Jan 9. J Leukoc Biol. 2014. PMID: 24407884 Free PMC article.

9

CCL20/CCR6 blockade enhances immunity to RSV by impairing recruitment of DC.

Kallal LE, Schaller MA, Lindell DM, Lira SA, Lukacs NW. Kallal LE, et al. Eur J Immunol. 2010 Apr;40(4):1042-52. doi: 10.1002/eji.200939778. Eur J Immunol. 2010. PMID: 20101616 Free PMC article.

10

The balance between plasmacytoid DC versus conventional DC determines pulmonary immunity to virus infections.

Smit JJ, Lindell DM, Boon L, Kool M, Lambrecht BN, Lukacs NW. Smit JJ, et al. PLoS One. 2008 Mar 5;3(3):e1720. doi: 10.1371/journal.pone.0001720. PLoS One. 2008. PMID: 18320041 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Results by year